Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
EarlySign Announces Strategic Collaboration Agreement with Roche on AI Solution for Early Detection of Lung Cancer
Medial EarlySign (earlysign.com), a pioneering company developing Artificial Intelligence (AI) based clinical predictive analytics, announced today […]
FUJIFILM Healthcare Europe Launches a Dedicated Prostate Fusion Imaging Platform
FUJIFILM Healthcare Europe is pleased to have unveiled the ARIETTA™ 65 IntuitiveFusion, a diagnostic ultrasound […]
Diabetes Patients Set to Benefit From Heart Disease Data Investment
People living with diabetes could be set to benefit from a major research initiative to […]
Azra AI Expands Innovative Incidental Findings Technology to Help Clinicians Identify More Cancers
Azra AI‘s proprietary software — which uses artificial intelligence (AI) and natural language processing to […]
Researchers Create a Single-cell Framework to Potentially Enhance CAR T-cell Therapy
St. Jude Children’s Research Hospital scientists have demonstrated that the long-term performance of cancer-killing chimeric […]
Statement from Steve Barclay, Secretary of State for Health and Social Care
Health and Social Care Secretary Steve Barclay said: It is an honour to take up […]
Thabor Therapeutics Secures €2 Million in Deep Tech Financing From Bpifrance
Thabor Therapeutics, a company developing an innovative treatment for patients living with chronic mucosal inflammatory […]
Novartis Pharmaceuticals UK Launches World-first Health-tech Investor Partnership to Reimagine Cardiovascular Care
Novartis Pharmaceuticals UK announces the launch of the Novartis Biome UK Heart Health Catalyst 2022, […]
Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets
Skyhawk Therapeutics, Inc. today announced the signing of an exclusive worldwide collaboration agreement with Sanofi […]
Enosi Therapeutics Partners with Danuo Science Group to Accelerate Multiple Therapeutic Programs
Enosi Therapeutics, a Delaware Corporation, focused on providing industry-leading therapeutics for cancer and autoimmune diseases, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more